ClinConnect ClinConnect Logo
Search / Trial NCT05243771

Norwegian Stoma Trial

Launched by THE HOSPITAL OF VESTFOLD · Feb 7, 2022

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

The Norwegian Stoma Trial is a research study looking at how different types of stomas (which are openings created for waste to leave the body) are used during surgery for rectal cancer. The main goal is to see how these stomas affect surgical complications, the quality of life after surgery, and the length of hospital stays for patients. This study is currently recruiting participants aged 18 and older who have been diagnosed with rectal adenocarcinoma, a type of cancer that begins in the rectum.

If you or a loved one is interested in participating, it's important to know that you will need to provide informed consent and have a tumor located within 15 centimeters of the anal opening. However, people with advanced cancer that requires more extensive surgery or those with other serious health issues may not be eligible. Participants can expect to be closely monitored during the trial, and the findings could help improve care for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 years or older
  • Verified rectal adenocarcinoma by biopsy
  • Tumor located in the rectum with lower border of the tumor located 15 cm or less from the anal verge.
  • Given informed consent
  • Exclusion Criteria:
  • Advanced tumor stage requiring exenterative surgery beyond a convetional APR or TME.
  • Stage IV disease
  • Synchronous colon cancer necessitating a total colectomy
  • Other concomitant disease(s) which will complicate participation.
  • Unwillingness to give informed consent

About The Hospital Of Vestfold

The Hospital of Vestfold is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence, the hospital collaborates with multidisciplinary teams to conduct rigorous studies across various therapeutic areas. Its state-of-the-art facilities and experienced research staff ensure high-quality data collection and analysis, fostering an environment conducive to groundbreaking discoveries. The Hospital of Vestfold prioritizes patient safety and ethical standards, striving to enhance treatment options and contribute to the global medical community.

Locations

Trondheim, , Norway

Bergen, , Norway

Skien, , Norway

Oslo, Lørenskog, Norway

Oslo, , Norway

Tønsberg, , Norway

Drammen, , Norway

Sarpsborg, Grålum, Norway

Oslo, , Norway

ålesund, , Norway

Tromsø, , Norway

Sarpsborg, , Norway

Bærums Verk, Gjettum, Norway

Bodø, , Norway

Gjøvik, , Norway

Hamar, , Norway

Haugesund, , Norway

Kristiansand, , Norway

Levanger, , Norway

Stavanger, , Norway

Patients applied

0 patients applied

Trial Officials

Lars Thomas Seeberg, MD, PhD

Principal Investigator

The Hospital of Vestfold

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials